NextTrial AI logo — Cloud-based, AI-powered, Smart Data Platform for Acceleratin...

NextTrial AI

Cloud-based, AI-powered, Smart Data Platform for Accelerating Clinical Research

Founded 2020 United States Bridgewater, United States 7 employees Information Technology

General Information

Company Name NextTrial AI
Founded Year 2020
Location United States Bridgewater, United States
Employees 7
Industries Information Technology
Social

BounceWatch is an independent company data service, not affiliated with NextTrial AI. To contact NextTrial AI, visit nexttrial.ai.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does NextTrial AI compare?

A PDF of NextTrial AI and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting NextTrial AI soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About NextTrial AI

NextTrial AI is a cloud-based, AI-powered, smart data platform that aims to accelerate clinical trial research and expedite the delivery of innovative medicines to patients. Based in the United States, the company offers a collaborative platform that leverages AI to streamline the clinical research process. The platform's innovative approach provides a dynamic solution to the challenges faced in the clinical trial space. As the demand for advanced healthcare solutions continues to rise, NextTrial AI presents an opportunity for venture capitalists seeking to invest in cutting-edge technology that intersects with the life sciences industry. With the potential to significantly impact the future of medicine, NextTrial AI stands out as an intriguing prospect for venture capital firms looking to align with pioneering ventures. The company's focus on leveraging AI for accelerating clinical research presents a viable entry point for investors seeking opportunities at the intersection of healthcare and technology.

Business keywords: Cloud-based platform, AI-powered, Smart data, Clinical research, Clinical trials, Collaborative, Innovative medicines, Artificial intelligence, Research acceleration, Medical technology, Patient-focused, Healthcare innovation

No funding data available for NextTrial AI yet.

NextTrial AI Alternatives & Competitors

View All Alternatives
NextTrial AI vs
QMENTA
QMENTA United States

Medical imaging software solutions that improve outcomes for research, and clinical trials

Debt Financing
45 employees
AI, Analytics
NextTrial AI vs
Q1.6
Q1.6 Belgium

Patient insights in 1.6 seconds

8 employees
Information Technology
NextTrial AI vs
uMed
uMed United States

Addressing Evidence Gaps in Life Science Research

Series A
65 employees
Digital Health, Health Care

FAQ About NextTrial AI

Cloud-based, AI-powered, Smart Data Platform for Accelerating Clinical Research
NextTrial AI was founded in 2020.
NextTrial AI is headquartered in Bridgewater, United States.
NextTrial AI operates in Information Technology. Its work centres on Cloud-based platform, AI-powered, Smart data and Clinical research.
NextTrial AI has approximately 7 employees.
Top alternatives and competitors to NextTrial AI include QMENTA, Q1.6, uMed, Invio, Inc., Healex. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
NextTrial AI and QMENTA are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for NextTrial AI, https://bouncewatch.com/company/nexttrial-ai, updated 31 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes